top of page


Peer-Reviewed Publications

[1] Penet MF, Sharma RK, Bharti S, Mori N, Artemov D, Bhujwalla ZM. Cancer Insights from MR Spectroscopy
of Cells and Excised Tumors. NMR Biomed. 2022 Mar 9:e4724. doi: 10.1002/nbm.4724. Online ahead of print.
PMID: 35262263 Review.

[2] Jin J, Sivakumar I, Mironchik Y, Krishnamachary B, Wildes F, Barnett JD, Hung CF, Nimmagadda S,
Kobayashi H, Bhujwalla ZM, Penet MF. PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model.
Cancers (Basel). 2022 Jan 26;14(3):619. doi: 10.3390/cancers14030619.PMID: 35158887 Free PMC article.

[3] Pacheco-Torres J, Penet MF, Mironchik Y, Krishnamachary B, Bhujwalla ZM. The PD-L1 metabolic
interactome intersects with choline metabolism and inflammation. Cancer Metab. 2021 Feb 19;9(1):10. doi:
10.1186/s40170-021-00245-w.PMID: 33608051 Free PMC article.

[4] Bie C, Li Y, Zhou Y, Bhujwalla ZM, Song X, Liu G, van Zijl PCM, Yadav NN. Deep learning-based
classification of preclinical breast cancer tumor models using chemical exchange saturation transfer magnetic
resonance imaging. NMR Biomed. 2022 Feb;35(2):e4626. doi: 10.1002/nbm.4626. Epub 2021 Oct
19.PMID: 34668251

[5] Ngen EJ, Chen Y, Azad BB, Boinapally S, Jacob D, Lisok A, Shen C, Hossain MS, Jin J, Bhujwalla ZM,
Pomper MG, Banerjee SR. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy
enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
Nanotheranostics. 2021 Jan 19;5(2):182-196. doi: 10.7150/ntno.52361. eCollection 2021.PMID: 33564617 Free
PMC article.

[6] Pacheco-Torres J, Penet MF, Krishnamachary B, Mironchik Y, Chen Z, Bhujwalla ZM. PD-L1 siRNA
Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor
PD-L1 Downregulation. Front Oncol. 2021 Feb 25;10:614365. doi: 10.3389/fonc.2020.614365. eCollection
2020.PMID: 33718115 Free PMC article.

[7] Penet MF, Kakkad S, Wildes F, Bhujwalla ZM. Water and Collagen Content Are High in Pancreatic Cancer:
Implications for Quantitative Metabolic Imaging. Front Oncol. 2021 Jan 27;10:599204. doi:
10.3389/fonc.2020.599204. eCollection 2020.PMID: 33585215 Free PMC article.

[8] Vagal A, Reeder SB, Sodickson DK, Goh V, Bhujwalla ZM, Krupinski EA. The Impact of the COVID-19
Pandemic on the Radiology Research Enterprise: Radiology Scientific Expert Panel. Radiology. 2020
Sep;296(3):E134-E140. doi: 10.1148/radiol.2020201393. Epub 2020 Apr 15.PMID: 32293224 Free PMC article.

[9] Krishnamachary B, Mironchik Y, Jacob D, Goggins E, Kakkad S, Ofori F, Dore-Savard L, Bharti SK, Wildes
F, Penet MF, Black ME, Bhujwalla ZM. Hypoxia theranostics of a human prostate cancer xenograft and the
resulting effects on the tumor microenvironment. Neoplasia. 2020 Dec;22(12):679-688. doi:
10.1016/j.neo.2020.10.001. Epub 2020 Oct 23.PMID: 33142234 Free PMC article.

[10] Chen Z, Krishnamachary B, Pachecho-Torres J, Penet MF, Bhujwalla ZM. Theranostic small interfering
RNA nanoparticles in cancer precision nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020
Mar;12(2):e1595. doi: 10.1002/wnan.1595. Epub 2019 Oct 23. PMID: 31642207 Free PMC article. Review.

[11] Jin J, Bhujwalla ZM. Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their
Applications in Cancer Theranostics. Front Oncol. 2020 Jan 21;9:1560. doi: 10.3389/fonc.2019.01560.
eCollection 2019.PMID: 32039028 Free PMC article.

[12] Chen Z, Krishnamachary B, Penet MF, Bhujwalla ZM. Acid-degradable Dextran as an Image Guided siRNA
Carrier for COX-2 Downregulation. Theranostics. 2018 Jan 1;8(1):1-12. doi: 10.7150/thno.21052. eCollection
2018.PMID: 29290789 Free PMC article.

[13] Bharti SK, Kakkad S, Danhier P, Wildes F, Penet MF, Krishnamachary B, Bhujwalla ZM. Hypoxia Patterns
in Primary and Metastatic Prostate Cancer Environments. Neoplasia. 2019 Feb;21(2):239-246. doi:
10.1016/j.neo.2018.12.004. Epub 2019 Jan 10.PMID: 30639975 Free PMC article.

[14] Penet MF, Shah T, Wildes F, Krishnamachary B, Bharti SK, Pacheco-Torres J, Artemov D, Bhujwalla ZM.
MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions. NMR Biomed.
2019 Oct;32(10):e4053. doi: 10.1002/nbm.4053. Epub 2019 Jan 28.PMID: 30693605 Free PMC article. Review.

[15] Bhujwalla ZM, Kakkad S, Chen Z, Jin J, Hapuarachchige S, Artemov D, Penet MF. Theranostics and
metabolotheranostics for precision medicine in oncology. J Magn Reson. 2018 Jun;291:141-151. doi:
10.1016/j.jmr.2018.03.004. Epub 2018 Apr 26.PMID: 29705040 Free PMC article. Review.

Book Chapters
[1] Penet M-F and Bhujwalla ZM. High-Resolution 1H MRS Metabolomics of Biofluids in Cancer. European
Biophysical Societies’ Association, 2022.

[2] Penet M-F, Kakkad S, Pacheco-Torres J, Bharti S, Krishnamachary, Bhujwalla ZM. Molecular and Functional
Imaging and Theranostics of the Tumor Microenvironment. In: Molecular Imaging: Principles and Practice, 2nd
Edition, Academic Press, 2021.

bottom of page